|
April. 24, 2023 |
|
|
July. 04, 2025 |
|
|
jRCTs062230007 |
Efficacy and safety of iStent inject with cataract surgery for primary angle closure glaucoma |
|
iStent inject with cataract surgery for primary angle closure glaucoma |
|
June. 27, 2024 |
|
6 |
|
No. Age (y) Gender Side (R/L) Baseline IOP (mmHg) No. glaucoma medication 1 83 Female L 15 3 2 64 Female L 15 2 3 62 Female R 16 0 4 65 Female R 16 4 5 74 Female R 12 2 6 64 Male L 18 0 |
|
The target number of cases is 7, with 6 cases enrolled, and the observation period for all 6 cases has ended. |
|
none |
|
Intraocular Pressure (number of glaucoma medications) No. Baseline 1d 1w 1m 3m 6m 1 15 (3) 15 (0) 15 (0) 13 (0) 14 (0) 14 (0) 2 15 (2) 11 (0) 12 (0) 12 (0) 14 (0) 15 (0) 3 16 (0) 12 (0) 12 (0) 12 (0) 10 (0) 9 (0) 4 16 (4) 15 (0) 14 (0) 15 (0) 16 (0) 16 (2) 5 12 (2) 15 (0) 13 (0) 14 (0) 14 (0) 17 (0) 6 18 (0) 24 (0) 18 (2) 18 (0) 14 (2) 14 (2) |
|
In patients with PACG, phacoemulsification with trabecular microbypass Stent W implantation was demonstrated to be a safe and effective procedure. |
|
April. 01, 2025 |
|
Nov. 30, 2024 |
|
https://pmc.ncbi.nlm.nih.gov/articles/PMC11685551/ |
No |
|
none |
|
https://jrct.mhlw.go.jp/latest-detail/jRCTs062230007 |
Hirooka Kazuyuki |
||
Hiroshima University Hospital |
||
Kasumi 1-2-3 Minami-ku, Hiroshima |
||
+81-82-257-4257 |
||
kazuyk@hiroshima-u.ac.jp |
||
Hirooka Kazuyuki |
||
Hiroshima University Hospital |
||
Kasumi 1-2-3 Minami-ku, Hiroshima |
||
+81-82-257-4257 |
||
onoehir@hiroshima-u.ac.jp |
Complete |
April. 24, 2023 |
||
| Aug. 03, 2023 | ||
| 7 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
1 Patients with primary angle closure glaucoma who are 18 years of age or older at the time of consent |
||
1 Patients complicated by phacodonesis or zonular weakness |
||
| 18age old over | ||
| No limit | ||
Both |
||
Primary angle closure glaucoma |
||
iStent inject with cataract surgery |
||
Primary angle closure glaucoma |
||
iStent |
||
D015812 |
||
intraocular pressure 6 months after surgery |
||
1 success rate: success is defined as IOP of 15 mmHg or less with IOP reduction of 20% or more (criterion 1) and IOP of 18 mmHg or less with IOP reduction of 20% or more (criterion 2). |
||
| Glaucos Japan | |
| Not applicable |
| the Ethical Committee on Clinical Investigation of Hiroshima University Hospital | |
| Kasumi 1-2-3 Minami-ku, Hiroshima, Hiroshima | |
+81-82-257-1551 |
|
| iryo-sinsa@office.hiroshima-u.ac.jp | |
| Approval | |
Mar. 08, 2023 |
none |